BE1003021A3 - PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND PROCESS FOR PREPARING THE SAME. - Google Patents

PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND PROCESS FOR PREPARING THE SAME. Download PDF

Info

Publication number
BE1003021A3
BE1003021A3 BE8900321A BE8900321A BE1003021A3 BE 1003021 A3 BE1003021 A3 BE 1003021A3 BE 8900321 A BE8900321 A BE 8900321A BE 8900321 A BE8900321 A BE 8900321A BE 1003021 A3 BE1003021 A3 BE 1003021A3
Authority
BE
Belgium
Prior art keywords
cardiac
preparing
pharmaceutical compositions
cardiovascular system
same
Prior art date
Application number
BE8900321A
Other languages
French (fr)
Inventor
Nagy Peter Literati
Hegedus Erzsebet Radvany
Maria Boros
Jeno Szilbereky
Gyoergy Blasko
Bela Gachalyi
Nemes Gizella Hamar
Gabor Nemeth
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Application granted granted Critical
Publication of BE1003021A3 publication Critical patent/BE1003021A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques agissant en particulier sur les états thrombo-emboliques du système cardiaque et cardiovasculaire, qui comprennent 0,5 à 50 % en masse d'un micro-organisme contenant du sélénium ainsi que 99,5 à 50 % en masse d'acides gras en C18-24 contenant aux moins deux liaisons insaturées ou leurs dérivés, éventuellement en mélange avec des véhicules et/ou des additifs couramment utilisés dans l'industrie pharmaceutique et éventuellement avec des antioxydants. En outre, l'invention concerne un procédé pour préparer ces compositions.The invention relates to pharmaceutical compositions which act in particular on the thromboembolic states of the cardiac and cardiovascular system, which comprise 0.5 to 50% by mass of a microorganism containing selenium as well as 99.5 to 50% by weight. mass of C18-24 fatty acids containing at least two unsaturated bonds or their derivatives, optionally in admixture with vehicles and / or additives commonly used in the pharmaceutical industry and optionally with antioxidants. Furthermore, the invention relates to a process for preparing these compositions.

BE8900321A 1988-03-23 1989-03-23 PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND PROCESS FOR PREPARING THE SAME. BE1003021A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Publications (1)

Publication Number Publication Date
BE1003021A3 true BE1003021A3 (en) 1991-10-29

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900321A BE1003021A3 (en) 1988-03-23 1989-03-23 PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND PROCESS FOR PREPARING THE SAME.

Country Status (15)

Country Link
JP (1) JPH0222228A (en)
KR (1) KR890014104A (en)
BE (1) BE1003021A3 (en)
CA (1) CA1319607C (en)
CH (1) CH677732A5 (en)
DE (1) DE3909707A1 (en)
ES (1) ES2014060A6 (en)
FI (1) FI891438L (en)
FR (1) FR2628972B1 (en)
GB (1) GB2216421A (en)
HU (1) HU210122B (en)
IT (1) IT1229205B (en)
LU (1) LU87488A1 (en)
NL (1) NL8900742A (en)
SE (1) SE8901041L (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (en) * 1990-11-06 2000-12-04 ソニー株式会社 Electronics
KR19990015198A (en) * 1997-08-02 1999-03-05 손남율 Vegetable antibiotics
BE1012495A3 (en) 1999-03-02 2000-11-07 Messadek Jallal Glycine betaine-for its use antithrombotic.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (en) * 2000-11-08 2005-04-01 Brif NEW DIETETIC AND / OR COSMETIC COMPOSITIONS FOR IMPROVING MUCOUS DROUGHT
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
CN1665496B (en) * 2002-05-03 2010-05-05 派普生物保健品公司 Use of EPA and DHA in the preparation of drugs for secondary prevention of neurological diseases
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (en) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition for regulation and cellular regeneration in the digestive tract, useful e.g. for treating gastroenteritis or improving animal performance, comprises essential oils, shark liver oil, selenium and water
AU2005270825B2 (en) * 2004-08-09 2011-07-07 Enzymotec Ltd. Food products for diabetics
AU2005270831B2 (en) 2004-08-10 2011-08-25 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (en) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Antiviral and immunostimulant pharmaceutical composition containing polyunsaturated fatty acid esters
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
ATE540690T1 (en) 2005-04-27 2012-01-15 Jallal Messadek INSULIN COMBINATIONS
ITMI20052483A1 (en) * 2005-12-23 2007-06-24 Novamont Spa BIODEGRADABLE LURES
FR2935393B1 (en) 2008-08-29 2012-08-24 Tetrahedron ORGANIC SELENIUM ENRICHED BACTERIA AND YEASTS FROM SELENO-HYDROXYACID COMPOUNDS AND THEIR NUTRITION, COSMETIC AND PHARMACY APPLICATIONS
FR2935394B1 (en) 2008-08-29 2013-03-08 Eco Solution ORGANIC SELENIUM-ENRICHED PHOTOSYNTHETIC MICROORGANISMS FROM SELENO-HYDROXYACID COMPOUNDS AND THEIR USE IN NUTRITION, COSMETICS AND PHARMACY

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2148713A (en) * 1983-10-24 1985-06-05 Century Lab Inc Pharmaceutical composition and food product comprising higher fatty acids
FR2612399A1 (en) * 1987-03-18 1988-09-23 Caola Kozmetikai PHARMACEUTICAL COMPOSITIONS ACTING ON THE HEART AND THE CARDIOVASCULAR SYSTEM AND PROCESS FOR THEIR PREPARATION
FR2612373A1 (en) * 1987-03-18 1988-09-23 Caola Kozmetikai DIETETIC COMPOSITIONS AND PROCESS FOR THEIR PREPARATION
GB2216418A (en) * 1988-03-09 1989-10-11 Biorex Kft Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2148713A (en) * 1983-10-24 1985-06-05 Century Lab Inc Pharmaceutical composition and food product comprising higher fatty acids
FR2612399A1 (en) * 1987-03-18 1988-09-23 Caola Kozmetikai PHARMACEUTICAL COMPOSITIONS ACTING ON THE HEART AND THE CARDIOVASCULAR SYSTEM AND PROCESS FOR THEIR PREPARATION
FR2612373A1 (en) * 1987-03-18 1988-09-23 Caola Kozmetikai DIETETIC COMPOSITIONS AND PROCESS FOR THEIR PREPARATION
GB2216418A (en) * 1988-03-09 1989-10-11 Biorex Kft Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids.

Also Published As

Publication number Publication date
SE8901041D0 (en) 1989-03-23
FI891438A7 (en) 1989-09-24
SE8901041L (en) 1989-09-24
FR2628972B1 (en) 1994-09-23
GB8906856D0 (en) 1989-05-10
DE3909707A1 (en) 1989-10-05
LU87488A1 (en) 1990-10-02
NL8900742A (en) 1989-10-16
CA1319607C (en) 1993-06-29
GB2216421A (en) 1989-10-11
IT1229205B (en) 1991-07-25
HU210122B (en) 1995-02-28
IT8919876A0 (en) 1989-03-23
FI891438L (en) 1989-09-24
FR2628972A1 (en) 1989-09-29
HUT60436A (en) 1992-09-28
KR890014104A (en) 1989-10-21
JPH0222228A (en) 1990-01-25
FI891438A0 (en) 1989-03-23
ES2014060A6 (en) 1990-06-16
CH677732A5 (en) 1991-06-28

Similar Documents

Publication Publication Date Title
BE1003021A3 (en) PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND PROCESS FOR PREPARING THE SAME.
HUT70536A (en) Arylsulfonamido-substituted hydroxamic acids, process for preparing them and pharmaceutical compositions containing them
HU9403795D0 (en) Highly concentrated immunoglobulin preparation and method for its production
EP0618259A3 (en) Thermoplastic elastomer, composition containing it and its preparation method as well as molding products obtained with this thermoplastic elastomer.
BE902874A (en) THERAPEUTIC COMPOSITIONS AND METHOD FOR THE TREATMENT OR PREVENTION OF PAF-ACETHER-CAUSED DISEASES
FR2440371A1 (en) NOVEL HETEROCYCLIC NITROGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS FOR PREPARING THE SAME
BE1002428A3 (en) PHARMACEUTICAL COMPOSITIONS ACTING ON THE HEART AND CARDIOVASCULAR SYSTEM AND PROCESS FOR THEIR PREPARATION.
FR2714059B1 (en) Branched amino derivatives of thiazole, processes for their preparation and pharmaceutical compositions containing them.
FR2449697A1 (en) NOVEL MURAMYL-PEPTIDES SUBSTITUTED ON PEPTIDE NITROGEN AND MEDICAMENTS CONTAINING THEM
FR2398112A1 (en) PROCESS FOR IMPROVING THE AROMA AND / OR THE FOAM OF SPARKLING WINE, CHAMPAGNISE WINE OR SPARKLING WINE AND THUS IMPROVED PRODUCTS
FR2392068A1 (en) PROCESS FOR THE PRODUCTION OF A COATED PARTICULAR FILLER FOR ORGANIC POLYMERS
FR2708609B1 (en) Methylguanidine derivatives, processes for their preparation and compositions containing them.
BE1002429A3 (en) DIETETIC COMPOSITIONS AND PROCESS FOR THEIR PREPARATION.
ATE41785T1 (en) MEMBRANE POLYSACCHARIDES, PARTICULARLY USED AS MEDICATIONS AND PROCESSES FOR THEIR PREPARATION.
HU9201005D0 (en) Leustroduxine derivatives, production and therapeutical application thereof
BE901433A (en) STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF KETOSIS AND METHOD FOR PREPARING THE SAME.
GR3007079T3 (en)
FR2612526B1 (en) PROCESS FOR THE PREPARATION OF AN OVERALCANIZED ADDITIVE CONTAINING A BORON DERIVATIVE, THE ADDITIVE THUS OBTAINED AND LUBRICANT COMPOSITIONS CONTAINING THE ADDITIVE
FR2642423B1 (en) PROCESS FOR THE PREPARATION OF PURIFIED FATTY ALKYLDIETHANOLAMIDES, THE PRODUCTS OBTAINED AND THEIR USES
FR2456474A1 (en) MAINTENANCE AGENT THAT CAN BE SPRAYED FROM A CONTAINER, AND METHOD FOR MAINTAINING MEDICAL INSTRUMENTS, ESPECIALLY DENTISTRY WITH SUCH AN AGENT
BE1001522A3 (en) COSMETIC COMPOSITIONS REGENERATING THE SKIN AND THEIR PREPARATION PROCESS.
KR950014314A (en) Moenomycin degradation products and moenomycin homologs having hydroxylated or oxidized lipid side chains, methods of making and using these compounds
ATE173922T1 (en) 2-ARYLPROPIONIC ACID PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF
BE901959A (en) INJECTABLE SOLUTION, ESPECIALLY FOR THE TREATMENT OF KETOSIS AND ITS PREPARATION METHOD.
AU4347389A (en) Novel s-timolol derivative and process for its preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BIOREX KFT

Effective date: 19960331